Literature DB >> 12610731

Paracrine role of soluble guanylate cyclase and type III nitric oxide synthase in ovine fetal pulmonary circulation: a double labeling immunohistochemical study.

Ching Tzao1, Peter A Nickerson, James A Russell, Bernice K Noble, Robin H Steinhorn.   

Abstract

Endothelial nitric oxide synthase (eNOS) or NOS-III in the endothelium catalyzes production of nitric oxide (NO). Nitric oxide diffuses freely into vascular smooth muscle, where it activates soluble guanylate cyclase (sGC) to produce guanosine 3',5'-cyclic monophosphate (cGMP) and causes vasorelaxation. The NO/cGMP pathway is an important signaling pathway in the control of perinatal pulmonary circulation. An exact colocalization of NOS-III in the pulmonary endothelium and sGC in the vascular smooth muscle was demonstrated using a double immunolabeling technique. The sGC immunoreactivity was higher in resistant pulmonary vessels and veins than in conduit arteries, whereas NOS-III immunoreactivity was higher in conduit arteries than in veins. These results demonstrated anatomically in situ a paracrine role of NOS-III and sGC in the regulation of fetal pulmonary circulation and suggested a heterogeneous distribution of NOS-III and sGC within fetal ovine pulmonary vasculature. Our results provided an anatomic basis that supported previous functional studies on perinatal control of pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610731     DOI: 10.1007/s00418-002-0494-z

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  25 in total

1.  The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. Homology between the two subunits of the enzyme.

Authors:  D Koesling; C Harteneck; P Humbert; A Bosserhoff; R Frank; G Schultz; E Böhme
Journal:  FEBS Lett       Date:  1990-06-18       Impact factor: 4.124

2.  Immunohistochemical demonstration of a paracrine role of nitric oxide in bronchial function.

Authors:  A Rengasamy; C Xue; R A Johns
Journal:  Am J Physiol       Date:  1994-12

3.  Heterogeneous distribution of soluble guanylate cyclase in the pulmonary vasculature of the fetal lamb.

Authors:  C A D'Angelis; P A Nickerson; R H Steinhorn; F C Morin
Journal:  Anat Rec       Date:  1998-01

4.  Regional variation of lamb blood vessel responsiveness to vasoactive agents during fetal development.

Authors:  C Su; J A Bevan; N S Assali; C R Brinkman
Journal:  Circ Res       Date:  1977-12       Impact factor: 17.367

Review 5.  Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.

Authors:  F Murad
Journal:  Adv Pharmacol       Date:  1994

6.  Persistent pulmonary hypertension of the newborn. Trends in incidence, diagnosis, and management.

Authors:  J R Hageman; M A Adams; T H Gardner
Journal:  Am J Dis Child       Date:  1984-06

7.  Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro.

Authors:  S H Abman; B A Chatfield; D M Rodman; S L Hall; I F McMurtry
Journal:  Am J Physiol       Date:  1991-04

8.  Heterogeneity in endothelium-derived nitric oxide-mediated relaxation of different sized pulmonary arteries of newborn lambs.

Authors:  Y Gao; J F Tolsa; J U Raj
Journal:  Pediatr Res       Date:  1998-11       Impact factor: 3.756

9.  Heterogeneity in role of endothelium-derived NO in pulmonary arteries and veins of full-term fetal lambs.

Authors:  Y Gao; H Zhou; J U Raj
Journal:  Am J Physiol       Date:  1995-04

10.  Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension.

Authors:  R H Steinhorn; J A Russell; F C Morin
Journal:  Am J Physiol       Date:  1995-04
View more
  5 in total

Review 1.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

2.  Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.

Authors:  Marc Chester; Gregory Seedorf; Pierre Tourneux; Jason Gien; Nancy Tseng; Theresa Grover; Jason Wright; Johannes-Peter Stasch; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-19       Impact factor: 5.464

3.  Pulmonary expression of nitric oxide synthase isoforms in sheep with smoke inhalation and burn injury.

Authors:  Robert A Cox; Sam Jacob; Gloria Oliveras; Kazunori Murakami; Perenlei Enkhbaatar; Lillian Traber; Frank C Schmalstieg; David N Herndon; Daniel L Traber; Hal K Hawkins
Journal:  Exp Lung Res       Date:  2009-03       Impact factor: 2.459

4.  Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.

Authors:  Marc Chester; Pierre Tourneux; Greg Seedorf; Theresa R Grover; Jason Gien; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-22       Impact factor: 5.464

5.  Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.

Authors:  T J Kulik; J E Lock
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.